A Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Single and Multiple Ascending Doses of ARGX-119 in Healthy Participants
NCT05670704
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
112
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Volunteers
Interventions
BIOLOGICAL:
ARGX-119
OTHER:
Placebo
Sponsor
argenx